Business

What are top 5 catalysts for psychedelic stocks in the second half of 2021? Stay tuned to hear how stocks...
Clinicians are currently using TRIPP to help immerse patients into alternative realities and to support patients’ wellbeing before, during, and...
This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes...
"A mushroom is not a pharmaceutical product," CEO Evan Levine stresses, and explains why his company's method of biologically engineering...
Check out atai Life Sciences' earnings call: https://www.youtube.com/watch?v=lkE3EmU0o_w What's up psychedelic stocks investors?!? Today marked MindMed's (MNMD /MMED) Second Quarter...
The company will use proceeds of the fundraising round to complete its ongoing Phase 1B trial on low-dose psilocybin in...
What's up psychedelic stocks investors?!? Today marked atai Life Science's (Nasdaq: atai) first-ever conference call, for Quarter 2, 2021. In...
MindMed's Financial Results & Business Update for Q2 2021 are out! In this episode, we'll discuss MindMed, ( MMED: NEO),...
The Psychedelic Spotlight podcast guest also addresses criticism that she is a white woman working with sacred plant medicine, and...
This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new...